Logo des HTGF

Portfolio Jobs

Browse through our portfolio jobs and select a suitable opportunity.

Our HTGF Portfolio of startups offers excellent opportunities and is always hiring talented people.

0
COMPANIES
0
JOBS

General Interest Application - Tubulis Talent Community (m/f/d)

Tubulis Technologies

Tubulis Technologies

People & HR
Munich, Germany · Bavaria, Germany · Germany
Posted on Sep 30, 2025
Be part of our team
Are you interested in joining our dynamic, innovative, and dedicated team focused on developing novel antibody-drug conjugates (ADCs) for the treatment of cancer, but don’t see a specific position that matches your interests or experience?

We’d still love to hear from you!

Please share your resume, tell us why you're interested in Tubulis, and the type of role you're looking for next. We'll add you to our talent community and be able to consider your experience and interest when new opportunities arise.
Why us?
At Tubulis, curiosity and innovation drive us to transform cancer treatment. We are a fast-growing biotech where science meets passion—and where you have the chance to grow with us.

  • Impact that matters: Contribute to breakthrough therapies.
  • Global mindset: Work in an international, diverse team.
  • Grow & thrive: Develop your career in a supportive, fast-moving environment.
  • Innovation every day: Push boundaries with cutting-edge science.
At Tubulis, your ideas matter, your growth matters—and together, we make a difference.
About us
The development of novel, effective and safe therapies for the treatment of cancer is one of the main challenges for modern medicine. We want to drive this process forward. The main goal of Tubulis is to become a leading company in the field of targeted therapeutics and antibody-drug conjugates (ADCs). With a strong team, our own technologies and innovative therapeutic concepts, we are ushering in a new era in the ongoing fight against cancer and share the vision of helping patients world-wide. Be part of a multidisciplinary and focused team, that works towards getting novel promising ADCs to patients with solid and hematological cancers.